Literature DB >> 20693204

Drug-induced subacute cutaneous lupus erythematosus.

J P Callen1.   

Abstract

Subacute cutaneous lupus erythematosus (SCLE) is a subset of cutaneous lupus erythematosus with unique immunologic and clinical features. The first description dates back to 1985 when a series of five patients were found to have hydrochlorothiazide-induced SCLE. Since that time, at least 40 other drugs have been implicated in the induction of SCLE.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20693204     DOI： 10.1177/0961203310370349

Source DB:  PubMed          Journal:  Lupus        ISSN： 0961-2033            Impact factor:   2.911


  6 in total

1.  Amlodipine-induced subacute cutaneous lupus.

Authors:  Alex G Ortega-Loayza; Calvin O McCall; Richard H Cooke; Ion S Jovin
Journal:  N Am J Med Sci       Date:  2013-03

2.  James Neil Gilliam, MD-the career arc of a patient-oriented translational clinical investigation changemaker in rheumatologic skin disease.

Authors:  Richard D Sontheimer
Journal:  Ann Transl Med       Date:  2018-06

Review 3.  Cutaneous lupus erythematosus: An update.

Authors:  Carina M Grönhagen; Filippa Nyberg
Journal:  Indian Dermatol Online J       Date:  2014-01

4.  Paraneoplastic subacute cutaneous lupus erythematosus with mucositis.

Authors:  James Abbott; J Skylar Westerdahl; David Wada; Stephanie Klein; Jason Mathis
Journal:  JAAD Case Rep       Date:  2022-02-17

5.  Proton pump inhibitor-induced subacute cutaneous lupus erythematosus.

Authors:  L H Sandholdt; R Laurinaviciene; A Bygum
Journal:  Br J Dermatol       Date:  2014-02       Impact factor: 9.302

6.  A pilot study evaluating biomarker development for drug-induced chronic eczematous eruptions of aging individuals.

Authors:  Erika Mae Summers; Nicholas Ray Blickenstaff; Garrett Curtis Coman; Thomas Bernd Martins; Harry Raymond Hill; Richard Dennis Sontheimer
Journal:  Ann Transl Med       Date:  2017-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.